Literature DB >> 26463982

A Hypothesis for the Role of RECK in Angiogenesis.

Jaime Gutiérrez1, Cristian A Droppelmann, Rocío Salsoso, Francisco Westermeier, Fernando Toledo, Carlos Salomon, Carlos Sanhueza, Fabián Pardo, Andrea Leiva, Luis Sobrevia.   

Abstract

Angiogenesis is a key process by which new capillary blood vessels are formed, sustaining the supply of oxygen and other nutrients to the body allowing its growth and wound healing, among others. However, angiogenesis also associates with pathological processes, such us tumor growth. Vascular endothelial cells produce different matrix remodeling enzymes such as matrix metalloproteinases and a-disintegrin and metalloproteinases, which have both positive and negative effects on angiogenesis, regulating the cell environment and signaling. However, little is known about the regulation of the activity of these proteases during vascular development. Reversion-inducing cysteine-rich protein with Kazal motifs (RECK) is a membrane-anchored inhibitor of different matrix metalloproteinases and a-disintegrin and metalloproteinases, being a critical regulator of extracellular matrix remodeling and signaling pathway, particularly Notch, which is critical for the maturation of the growing vessels. Reck knockout mice die in utero showing vascular developmental defects and massive hemorrhages. These defects were not observed in knockout mice for secreted-soluble matrix metalloproteinase inhibitors pointing to an exclusive role of RECK in vascular development and maturation since its location at the plasma membrane. Despite the above, the exact role of RECK in this process has not been clarified. This review is focused to summarize the available information on the role of RECK as membrane anchored matrix metalloproteinases and a-disintegrin and metalloproteinases inhibitor, proposing a hypothesis by which RECK play key roles in the physiology and pathophysiology of the angiogenesis processes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26463982     DOI: 10.2174/1570161113666151014130746

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  6 in total

1.  A systematic review of extracellular vesicles as non-invasive biomarkers in glioma diagnosis, prognosis, and treatment response monitoring.

Authors:  Arman Sourani; Saeid Saghaei; Masih Sabouri; Masoud Soleimani; Leila Dehghani
Journal:  Mol Biol Rep       Date:  2021-08-30       Impact factor: 2.316

Review 2.  Role of microRNAs and Exosomes in Helicobacter pylori and Epstein-Barr Virus Associated Gastric Cancers.

Authors:  Iva Polakovicova; Sofia Jerez; Ignacio A Wichmann; Alejandra Sandoval-Bórquez; Nicolás Carrasco-Véliz; Alejandro H Corvalán
Journal:  Front Microbiol       Date:  2018-04-05       Impact factor: 5.640

Review 3.  Role of Tumor-Derived Extracellular Vesicles in Glioblastoma.

Authors:  Yunping Chen; Yan Jin; Nan Wu
Journal:  Cells       Date:  2021-02-28       Impact factor: 6.600

Review 4.  The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH.

Authors:  Ryan J Dashek; Connor Diaz; Bysani Chandrasekar; R Scott Rector
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-20       Impact factor: 5.555

Review 5.  Insulin Is a Key Modulator of Fetoplacental Endothelium Metabolic Disturbances in Gestational Diabetes Mellitus.

Authors:  Luis Sobrevia; Rocío Salsoso; Bárbara Fuenzalida; Eric Barros; Lilian Toledo; Luis Silva; Carolina Pizarro; Mario Subiabre; Roberto Villalobos; Joaquín Araos; Fernando Toledo; Marcelo González; Jaime Gutiérrez; Marcelo Farías; Delia I Chiarello; Fabián Pardo; Andrea Leiva
Journal:  Front Physiol       Date:  2016-03-31       Impact factor: 4.566

6.  Nimbolide upregulates RECK by targeting miR-21 and HIF-1α in cell lines and in a hamster oral carcinogenesis model.

Authors:  Jaganathan Kowshik; Rajakishore Mishra; Josephraj Sophia; Satabdi Rautray; Kumaraswamy Anbarasu; G Deepak Reddy; Madhulika Dixit; Sundarasamy Mahalingam; Siddavaram Nagini
Journal:  Sci Rep       Date:  2017-05-17       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.